Search

Author/Creator Bral, Samuel

1. Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium. Issue 3 (March 2023)

Authors:
Kroeze, Stephanie G C; Pavic, Matea; Stellamans, Karin; Lievens, Yolande; Becherini, Carlotta; Scorsetti, Marta; Alongi, Filippo; Ricardi, Umberto; Jereczek-Fossa, Barbara Alicja; Westhoff, Paulien; But-Hadzic, Jasna; Widder, Joachim; Geets, Xavier; Bral, Samuel; Lambrecht, Maarten; Billiet, Char...
Journal:
Lancet oncology
Issue:
Volume 24:Issue 3(2023)
Page Start:
e121
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Once‐a‐week or every‐other‐day urethra‐sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow‐up results. (11th March 2020)

Authors:
Zilli, Thomas; Jorcano, Sandra; Bral, Samuel; Rubio, Carmen; Bruynzeel, Anna M.E.; Oliveira, Angelo; Abacioglu, Ufuk; Minn, Heikki; Symon, Zvi; Miralbell, Raymond
Journal:
Cancer medicine
Issue:
Volume 9:Number 9(2020)
Page Start:
3097
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search